Company Description
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jul 28, 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 992 |
| CEO | Daniel L. Reuvers |
Contact Details
Address: 1331 Tyler Street Ne Ste 200 Minneapolis, Minnesota 55413 United States | |
| Phone | 866-435-3948 |
| Website | tactilemedical.com |
Stock Details
| Ticker Symbol | TCMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001027838 |
| CUSIP Number | 87357P100 |
| ISIN Number | US87357P1003 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Daniel L. Reuvers | President, Chief Executive Officer and Director |
| Elaine M. Birkemeyer | Chief Financial Officer |
| Kristie T. Burns | Senior Vice President of Marketing and Clinical Affairs |
| Sherri Ferstler | Senior Vice President of Sales |
| Jerry A. Sauber | Senior Vice President of Manufacturing, Operations, Research & Development |
| John David Kaercher | Chief Information Officer |
| Sunday J. Hoy Esq. | Vice President and Compliance Officer |
| Janelle M. Strop | Chief Human Resource Officer |
| Dr. Antonios P. Gasparis F.A.C.S., M.D. | Chief Medical Officer and Member of Vascular Strategic Advisory Board |
| Rachel L. Gustad | Senior Vice President of Commercial Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 23, 2024 | 8-K | Current Report |
| Mar 27, 2024 | ARS | Filing |
| Mar 27, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 27, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 15, 2024 | PRE 14A | Other preliminary proxy statements |
| Feb 29, 2024 | 144 | Filing |
| Feb 29, 2024 | 144 | Filing |
| Feb 27, 2024 | 144 | Filing |
| Feb 27, 2024 | 144 | Filing |